文献速递神经MR

神经肿瘤学中的数字孪生:当前实现、技术策略与临床应用的系统综述

Digital Twins in Neuro-Oncology: A Systematic Review of Current Implementations, Technical Strategies, and Clinical Applications.
PubMed 文献 · Radiol Imaging Cancer · 2026-01-01

该系统综述检索PubMed、Scopus和Web of Science至2025年6月,纳入21篇神经肿瘤数字孪生研究,多数基于机制或生物物理框架,常用MRI数据模拟肿瘤生长与治疗反应,预测准确性较高但实时整合、多模态融合与外部验证有限。

要点

  • 数字孪生多基于机制或生物物理框架,近年人工智能与混合方法增多。
  • 17项研究主要依赖MRI数据,12项聚焦胶质母细胞瘤或高级别胶质瘤。
  • 仅6项提供公开代码,8项报告闭环校准,外部验证有限。

核心结论

  • 数字孪生在前沿神经肿瘤学中显示出个性化建模与治疗优化的潜力,但可重复性、多模态整合及外部验证仍有限,反映方法异质性。

研究设计与样本

  • 系统综述,检索PubMed、Scopus和Web of Science建库至2025年6月的英文原创研究,最终纳入21篇文献,使用PROBAST评估偏倚风险与适用性。

诊断标准与关键数值

  • 预测准确度及与临床数据的相关性普遍较高,但具体数值原文未报告。
  • PROBAST评估显示预测因子和结局定义明确,但参与者和分析方面频繁存在担忧。

局限性

  • 实时整合、多模态数据融合和外部验证有限。
  • 仅6项研究提供公开代码,8项报告闭环校准。
  • 方法异质性影响可重复性。
  • PROBAST评估在参与者和分析方面频繁存在担忧。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To perform a systematic review evaluating current digital twin (DT) implementations, highlighting clinical relevance and technical strategies, and identifying opportunities to advance personalized, predictive care in neuro-oncology. Materials and Methods PubMed, Scopus, and Web of Science databases were systematically screened for English-language original research articles published from inception through June 2025 focused on DT development, validation, or patient-specific computational models in neuro-oncology. Extracted variables included computational frameworks, data sources, clinical or predictive tasks, and reported outcomes. Risk of bias and applicability were assessed using the Prediction model Risk Of Bias ASsessment Tool (PROBAST), which revealed well-defined predictors and outcomes but frequent concerns regarding participants and analysis. Results Of the 73 articles reviewed, 21 met eligibility criteria. DTs simulated tumor growth, radiation response, immune interactions, and drug transport.Most models (n = 20) relied on mechanistic or biophysical frameworks, with increasing adoption of artificial intelligence-driven and hybrid approaches. A total of 12 studies focused on glioblastomas or high-grade gliomas, and 17 relied primarily on MRI data. Tumor-growth and treatment-response simulations were the most common DT applications. Only six studies provided publicly available code, and closed-loop calibration was reported in eight studies. Predictive accuracy and correlation with clinical data were generally high, but real-time integration, multimodal data fusion, and external validation were limited. Conclusion DTs showed promise for advancing personalized neuro-oncology, with demonstrated potential in modeling tumor behavior and optimizing therapies. Applications relied mainly on mechanistic artificial intelligence methods. Despite strong predictive performance, reproducibility, multimodal integration, and external validation remained limited, reflecting method heterogeneity. Keywords: Digital Twins, Neuro-oncology, Computational Modeling, Mechanistic Models, Brain Tumor, Precision Medicine Supplemental material is available for this article. © RSNA, 2026.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Singh A, Qureshy FA, Kurtz A, et al. Digital Twins in Neuro-Oncology: A Systematic Review of Current Implementations, Technical Strategies, and Clinical Applications. Radiol Imaging Cancer. 2026. PMID: 41823607. doi:10.1148/rycan.250567

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。